Article
Discovery of the first selective M <sub>4</sub> muscarinic acetylcholine receptor antagonists with <i>in vivo</i> anti-parkinsonian and anti-dystonic efficacy
2020-10-12
Abstract excerpt
Non-selective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson disease and dystonia. Despite their efficacy in these and other central nervous system disorders, anti-muscarinic therapy has limited utility due to severe adverse effects that often limit their tolerability by patien...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 06b7b611-e823-5b90-8b1f-b961b2443ceb
- DOI
- 10.1101/2020.10.12.324152
